NovoCure Ltd (NASDAQ: NVCR) is -35.47% lower on its value in year-to-date trading and has touched a low of $11.70 and a high of $34.13 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVCR stock was last observed hovering at around $21.96 in the last trading session, with the day’s loss setting it -2.73%.
Currently trading at $19.23, the stock is -13.82% and -26.67% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.8 million and changing -12.43% at the moment leaves the stock -7.64% off its SMA200. NVCR registered 29.06% gain for a year compared to 6-month gain of 5.95%.
The stock witnessed a -24.79% loss in the last 1 month and extending the period to 3 months gives it a 8.46%, and is -11.18% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.88% over the week and 4.41% over the month.
NovoCure Ltd (NVCR) has around 1453 employees, a market worth around $2.08B and $577.74M in sales. Profit margin for the company is -25.93%. Distance from 52-week low is 64.36% and -43.66% from its 52-week high. The company has generated returns on investments over the last 12 months (-31.27%).
with sales reaching $148.61M over the same period.The EPS is expected to shrink by -27.01% this year, but quarterly earnings will post 1.57% year-over-year. Quarterly sales are estimated to grow 7.30% in year-over-year returns.
The shares outstanding are 108.10M, and float is at 97.30M with Short Float at 5.34%.
The top institutional shareholder in the company is FMR LLC with over 16.14 million shares valued at $276.51 million. The investor’s holdings represent 15.0482 of the NVCR Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 12.13 million shares valued at $207.83 million to account for 11.3106 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 11.7 million shares representing 10.8601 and valued at over $200.36 million, while VANGUARD GROUP INC holds 10.3736 of the shares totaling 11.13 million with a market value of $190.61 million.
NovoCure Ltd (NVCR) Insider Activity
Still, SEC filings show that on Feb 27 ’25, WILHELMUS GROENHUYSEN (Officer) Proposed Sale 7,211 shares at an average price of $20.02 for $0.14 million. The insider now directly holds shares of NovoCure Ltd (NVCR).
